Neel Patel, DO
Cardiovascular Disease · San Diego, CANPI 1013176999
Payments from drug & device makers
What this record shows
Abbott accounts for 85.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $984 and has fallen 96.4% since, to $36 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in CA, where the typical reported total is $2,142.
Across 22 payments — averaging $79.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Medtronic$89
- Lantheus Medical Imaging, Inc.$55
- Angiodynamics, Inc.$52
- Philips North America LLC$23
- Boston Scientific$19
- plus $15 from 1 others
Across 1 payment — averaging $26,844 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$27K
What the payments were for
- Travel & lodging$86850%
- Food & beverage$87950%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $1,494 |
| Medtronic(2 entities) | 2 | $89 |
| Lantheus Medical Imaging, Inc. | 3 | $55 |
| Angiodynamics, Inc. | 1 | $52 |
| Philips North America LLC | 1 | $23 |
| Boston Scientific | 1 | $19 |
| Biosense Webster, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$348
- Mitra Clip system$122
How this compares
$1,747 in reported general payments places this provider in the 45th percentile of 2,184 cardiovascular disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 15 | $363,796 |
| EliquisApixaban | 248 | $348,625 |
| EntrestoSacubitril/Valsartan | 112 | $130,239 |
| Repatha SureclickEvolocumab | 92 | $103,801 |
| PradaxaDabigatran Etexilate Mesylate | 321 | $89,025 |
| BrilintaTicagrelor | 25 | $34,711 |
| Repatha SyringeEvolocumab | 25 | $34,586 |
| JardianceEmpagliflozin | 56 | $31,669 |
| XareltoRivaroxaban | 14 | $19,117 |
| Diltiazem 12hr ErDiltiazem Hcl | 47 | $17,991 |
| Repatha PushtronexEvolocumab | 11 | $9,689 |
| Potassium Chloride | 201 | $8,406 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 43 | $7,157 |
| Metoprolol Succinate | 300 | $4,453 |
| Furosemide | 327 | $4,450 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in San Diego
- Lori DanielsSan Diego$278K
- Michael WilkinsonSan Diego$145K
- Ted LoveHillsborough$102.8M
- Paul KurthSanta Barbara$6.1M
- Jason RogersSacramento$4.4M
- Matthew BudoffTorrance$3.6M
- Eric Topolla Jolla$2.2M
- Cathleen Bairey-MerzLos Angeles$1.2M
- Gagan SinghSacramento$1.2M
- Pam Taubla Jolla$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.